Skip to content
Screener
HTF

Heartflow, Inc.

HTFL

Heartflow is a medical technology company providing an AI-powered software platform for the non-invasive diagnosis and management of coronary artery disease (CAD).

Market cap
$4.93B+65.3%
Revenue$238.7M+47.4%
Net income-$79.0M+37.0%
Free cash flow-$56.1M+8.0%
Trailing twelve months · change vs. prior year

Earnings

Next report

Date not yet announced

Financials

Q3 2026

Income statement

See full
Revenue$72.9M+57.4%
Gross profit$60.9M+72.0%
Operating income-$13.8M+8.3%
Net income-$11.5M+77.4%
EPS (diluted)-$0.13+87.5%

Balance sheet

See full
Cash & equivalents$36.4M-87.7%
Total debt$25.9M+19.0%
Total equity$282.5M+11.0%
Total assets$355.3M-2.5%

Cash flow

See full
CapEx$1.4M+13.4%
Free cash flow-$1.1M+74.3%

Valuation & ratios

Valuation

See full
Market cap$4.93B+65.3%
Enterprise value$4.92B+93.0%
P/S20.6×+3.2×

Profitability

See full
Gross margin81.8%+6.2pp
Operating margin-33.1%-4.1pp
Net margin-33.1%-12.1pp
FCF margin-23.5%-6.4pp

Returns & leverage

See full
Return on equity-29.4%—
Debt / equity0.1×0.0×
Current ratio4.4×-4.3×

Competitors

Profile

Heartflow is a medical technology company providing an AI-powered software platform for the non-invasive diagnosis and management of coronary artery disease (CAD). The company leverages deep learning and computational fluid dynamics to create personalized 3D models of a patient's heart from standard CCTA scans, delivering actionable insights on blood flow and plaque composition. Its core value proposition is reducing the need for invasive procedures while improving the accuracy of CAD detection compared to traditional stress-based testing.

Competitive position

Heartflow is a leading provider of AI-powered CAD testing, with its flagship FFRCT product representing the vast majority of its revenue and holding significant clinical validation through major trials.

GeographiesUnited States
Customer segmentsHealthcare Providers, Diagnostic Imaging Centers
Business modelSaaS, Usage-based, Cloud-based software
SuppliersCCTA scanner manufacturers, Cloud infrastructure providers, Medical imaging data
CustomersInterventional cardiologists, Diagnostic radiologists, Hospital systems, Health insurance payers

FAQ

What is Heartflow, Inc.'s market cap?
Heartflow, Inc. (HTFL) has a market capitalization of $4.9B and trades on NASDAQ.
What is Heartflow, Inc.'s revenue and profitability?
Heartflow, Inc. generated $238.7M in trailing twelve-month revenue with a net loss of $79.0M, representing a net margin of -33.1%. Gross margin stands at 81.8%, with free cash flow of -$56.1M. The latest reported period is Q3 2026.
Who are Heartflow, Inc.'s competitors?
Heartflow, Inc.'s key competitors include GE HealthCare, Integer Holdings Corporation, Boston Scientific Corp., and others. These companies compete in similar markets and product categories.
Who does Heartflow, Inc. partner with?
Heartflow, Inc.'s notable partners include American Heart Association, American College of Cardiology.
Where is Heartflow, Inc. headquartered?
Heartflow, Inc. is headquartered in United States of America. It has been publicly traded since 2025.